EN
HI
Lincoln Pharmaceuticals Chart
Lincoln Pharmaceuticals Share Key Metrics
Volume
1.92 L
Market Cap
1252.96 CR
LTQ@LTP
1@625.55
ATP
640.29
Var Margin
22.71 %
Circuit Range
495.65-743.45
Delivery %
0 %
Value
12.31 CR
ASM/GSM
No
Market Lot
1
Summary
Lincoln Pharmaceuticals share price is ₹625.55 as of 6 Jun, 2026. The stock Lincoln Pharmaceuticals intraday movement has stayed between ₹620.00 and ₹657.00, while on a 52-week basis,Lincoln Pharmaceuticals price 52 week high is ₹770.00 & its 52 week low is ₹440.00.
In terms of trading activity, Lincoln Pharmaceuticals has recorded a volume of 192276 shares, The Lincoln Pharmaceuticals has a market cap of ₹20029728 CR. The stock’s Average Traded Price (ATP) stands at ₹640.29, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹625.55.
Lincoln Pharmaceuticals operates within a circuit range of ₹495.65 – ₹743.45, with a Value of ₹12.31 CR. The Delivery Percentage for the day is 0%. Additionally, Lincoln Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Lincoln Pharmaceuticals Fundamentals
P/E Ratio
14.24
P/B Ratio
1.65
Div. Yield
0.29
Sector P/E
68.9
Sector P/B
2.97
Sec. Div. Yield
0.54
Lincoln Pharmaceuticals Resistance and Support
Pivot 609.85
Resistance
First Resistance
633.7
Second Resistance
647.85
Third Resistance
671.7
Support
First Support
595.7
Second Support
571.85
Third Support
557.7
Lincoln Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-28 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
Lincoln Pharmaceuticals News
Lincoln Pharmaceuticals Ltd - 531633 - Corporate Action-Board approves Dividend
Lincoln Pharma board recommended a dividend of ₹1.80 per share (18%) for FY26. This is subject to approval at the upcoming Annual General Meeting.
May 28 2026 17:21:19
Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended 31St March, 2026.
Lincoln Pharma's board approved audited consolidated financial results for FY26, reporting a net profit of ₹87.89 crore, up 6.74% YoY, and revenue of ₹704.48 crore, up 9.10% YoY. The company also recommended an 18% dividend of ₹1.80 per share for the fiscal year.
May 28 2026 17:09:01
Read More
Lincoln Pharmaceuticals Management
| Name | Position |
|---|---|
| Trusha Shah | Company Secretary & Compliance Officer |
| Kishor M Shah | Chairman |
Lincoln Pharmaceuticals FAQs
The Buying Price of Lincoln Pharmaceuticals share is 625.55 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Lincoln Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Lincoln Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Lincoln Pharmaceuticals shares is 14.24. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Lincoln Pharmaceuticals shares is 1.65. Useful to assess the stock's value relative to its book value.
To assess Lincoln Pharmaceuticals’s valuation compare Sector P/E, P/B which are 68.9 & 2.97 with sector averages, along with growth rates and financial metrics.
The Market Cap of Lincoln Pharmaceuticals is 1252.96 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Lincoln Pharmaceuticals share price is 770.00 & 440.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Lincoln Pharmaceuticals belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
